Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US Amjevita Sales Slide By Almost Two-Thirds
Amgen’s Humira Biosimilar Turnover Slides In US Ahead Of Fresh Wave Of Launches
Aug 04 2023
•
By
David Wallace
Amgen saw US sales of its Humira biosimilar drop by nearly two-thirds in Q2 • Source: Shutterstock
More from Biosimilars
More from Products
